InvestorWire NewsRoom

Articles

Articles Category: TinyGems
Home / InvestorWire NewsRoom / Articles / Articles Category: TinyGems
Tuesday Aug 08, 2023 - 9:45 am

GEMXX Corp. (GEMZ) Announces Significant Progress Regarding Financing for Gold and Ammolite Mining Operations

The company offers an approach that gives them a cost-saving edge over other producers in the market Preliminary discussions have been made to shortlist engineering firms capable of conducting the necessary SK-1300 technical reports for the company’s newest gold and Ammolite assets – with anticipated completion by the end of FY-2023 GEMXX is participating in Regulation A financing, and interested investors, shareholders, institutions, and financiers,…

Continue Reading

Tuesday Aug 08, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates ‘Strategically Important’ New Patent Granted in the US

Lexaria recently celebrated the receipt of its 35th overall granted patent worldwide when the USPTO recently awarded US patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine” The company described the new patent as “strategically important” The patent positions the company to tap into the growing oral nicotine market and offers protection in one of the world’s leading oral nicotine markets This patent…

Continue Reading

Friday Aug 04, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Incorporates New Subsidiary, Lexaria Nutraceutical Corp., for Non-Pharmaceutical, Non-Nicotine, and Non-Cannabis DehydraTECH(TM) Formulations

Lexaria Nutraceutical Corp. will keep Lexaria’s overall strategy of maximizing the company’s patented DehydraTECH(TM) technology in various markets, excluding pharmaceutical, nicotine, and cannabis molecules Lexaria Pharmaceutical Corp.’s licensing was amended so as to solely focus on pharmaceutical formulations excluding nicotine Lexaria announced in early May that its nicotine trial, NIC-H22-1, had completed dosing with results expected in the near future NIC-H22-1 is anticipated to intercede…

Continue Reading

Thursday Aug 03, 2023 - 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Joins AMACARGA, Expanding Footprint, Capabilities, and Industry Presence

Fr8Tech just announced its move to join AMACARGA to expand its capabilities to cater to the growing demands of its clients importing goods from Asia The company’s association with AMACARGA affords it exceptional expertise and adherence to industry standards, bolstering its reputation in the industry The move further compounds Fr8Tech’s aggressive partnerships and collaborations plan, having recently announced its association with Trucker Tools, an automated…

Continue Reading

Friday Jul 28, 2023 - 9:45 am

Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China with Chinese Patent

Genprex recently received a patent in China covering the use of its drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers The REQORSA-Keytruda drug combination is the subject of Genprex’s ongoing Acclaim-2 clinical trial, which targets patients with advanced, metastatic non-small cell lung cancer whose disease progressed after treatment with Keytruda The company has received patent protection for…

Continue Reading

Friday Jul 21, 2023 - 9:00 am

National GBM Awareness Events Underscore Significance of Clinical Trial Progress for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)

National awareness of glioblastoma tumors (“GBM”) sustained by Congressional leaders aim to improve efforts to treat brain cancers and ultimately improve patient survival GBM is a widely occurring, aggressive and effectively incurable brain cancer that few patients survive beyond three years U.S.-based drug developer CNS Pharmaceuticals is in the midst of a global potentially pivotal clinical trial for its lead pharmaceutical candidate, Berubicin, which it…

Continue Reading

Friday Jun 30, 2023 - 2:40 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Published Peer-Reviewed Article on DehydraTECH(TM)-CBD, Bringing Publication Total to Eight

Lexaria’s latest peer-reviewed publications were published in June 2023 in the International Journal of Molecular Sciences, Advances in Therapy, and Biomedicine & Pharmacotherapy Lexaria’s eight peer-reviewed publications support the company’s pursuit of launching an FDA-registered IND program to formally investigate DehydraTECH(TM)-CBD for hypertension The global cardiovascular drug market was worth $146.5 billion and is expected to reach $173.5 billion in 2026 – making patent protection…

Continue Reading

Friday Jun 30, 2023 - 11:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Announces a Significant Development for Platform Users –Samsara Integration

FRGT just announced its new integration with Samsara, the pioneer of Connected Operations(TM) Cloud The move is seen as a “gamechanger,” with Fr8App customers now able to view and leverage insights from Samsara’s vehicle telematics solution Fr8App’s management is confident that by connecting with industry leaders like Samsara, the company will continue to pave the way for streamlined logistics processes and improved visibility for customers…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).